When medication stops working for people with congestive heart failure there are few options. A few months ago, Joe Knox couldn't take a simple walk due to his congestive heart failure. "I couldn't ...

MINNEAPOLIS, March 02, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for ...

WILMINGTON, NC (WWAY) — Novant Health New Hanover Regional Medical Center is offering the Barostim implant for heart failure patients. The first local recipient, Chuck Moon, says the results have been ...

CVRx, Inc. announced at the Technology and Heart Failure Therapeutics (THT) conference that new real-world evidence demonstrates significant reductions in hospital visits and length of stay after ...

Chuck Moon, a congestive heart failure patient, experienced significant improvement in his quality of life after receiving a Barostim device implant. The Barostim device is a new technology that acts ...

A new device called Barostim is helping heart failure patients at Christ Hospital in Cincinnati live more normal lives without major surgery, as experienced by local grandfather Eric Townsend.For ...

Study is Expected to Be One of the Largest Therapeutic Cardiac Device Trials in Heart Failure Ever Performed, and is Supported by CMS Category B IDE Coverage MINNEAPOLIS, Jan. 22, 2026 (GLOBE NEWSWIRE ...

CVRx, Inc. (NASDAQ: CVRX) on Thursday initiated the BENEFIT-HF clinical trial, a landmark randomized study supported by CMS Category B IDE coverage and designed to evaluate the impact of Barostim in a ...

MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc (CVRX). (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the American Medical Association (AMA) CPT® ...

CVRx, Inc., a private medical device company, announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled clinical trial were presented at the 2015 annual ...